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ABSTRACT: Droplet microﬂuidic technology is applied for
the high-throughput synthesis via Michael-type addition of
reactive, micrometer-sized poly(ethylene glycol) (PEG) hydro-
gels (“microgels”) with precisely controlled dimension and
physicochemical properties. A versatile chemical scheme is
used to modify the reactive PEG microgels with tethered
biomolecules to tune their bioactive properties for the
bioreactor culture and manipulation of various (stem) cell
types.
■ INTRODUCTION
Synthetic bioactive hydrogels such as those formed from
poly(ethylene glycol) (PEG) have emerged as powerful tools to
rationally manipulate cell behavior in vitro and in vivo.1,2
Indeed, a wealth of highly selective cross-linking chemistries
and well-deﬁned gel building blocks aﬀord the fabrication of
tunable gels that can mimic key properties of a cell’s native
extracellular matrix (ECM) in an unprecedented manner.3
These artiﬁcial ECM (aECM) gels are used in various
biomedical applications including tissue regeneration, cell
culture, or diagnostic platforms. A particularly promising area
to exploit the full potential of aECMs is the “ex vivo” (or in
vitro) manipulation of stem cells, for example, to expand stem
cells to larger numbers for clinical applications by mimicking
key functions of natural stem cell microenvironments (niches).4
That is to say, stem cell function in vivo is critically inﬂuenced
by signals from the stem cell niche,5 in the absence of which
most adult stem cells rapidly lose their multipotency. Thus,
generating in vitro platforms that recapitulate niche signaling
during cell culture can be critical for successful in vitro
manipulation of stem cells.
In contrast to many “classical” hydrogel families such as
those formed from natural ECM- or plant-derived proteins or
sugars (e.g., gelatin, collagen, alginate or agarose gels), thus far,
aECM gels have mostly been applied in stem cell culture as
bulk materials; that is, their synthesis has not been widely
interfaced with microtechnologies. The ability to miniaturize
the size of hydrogels from the centi- or millimeter to the
micrometer scale oﬀers new perspectives to engineer tissue
models and to study cell behavior in vitro.6 For example,
microscale approaches for gel synthesis such as the bottom-up
assembly of microgels enable the fabrication of 3D constructs as
models of native tissues, as demonstrated over the years by the
Khademhosseini lab7,8 and others.9−11 Therefore, the goal of
this work was the high-throughput generation of miniaturized
aECM gels for applications in stem cell biology and
biotechnology.
As a ﬁrst target to apply such a platform technology, we
focused on the generation of aECM microgels for the adherent
culture of stem cells in bioreactors, a powerful method to
generate large amounts of cells for clinical purposes.12,13
Accordingly, such microcarriers fabricated from diﬀerent
materials including polystyrene, cellulose, glass, or dextran
have been used for several decades in the pharmaceutical
industry, for example, for the large-scale production of proteins
or viruses.14,15 However, despite the fact that several micro-
carrier families have been tested for the expansion of stem cells
in bioreactors,16−24 to the best of our knowledge, none of the
existing microcarrier systems can be readily engineered to
confer biochemical and biophysical properties that are
reminiscent of those of native stem cell niches.
Here we combine hydrogel engineering with droplet
microﬂuidic technology25−27 to form aECM microgels in
high-throughput. Michael-type addition chemistry was used to
produce PEG microgels with modular dimension, stiﬀness and
surface-tethered biomolecule composition. Such modularity
allows tailoring microgel properties to a speciﬁc cell type and
cell function of interest, for example to stimulate the robust
expansion or diﬀerentiation of stem cells via display of speciﬁc
niche components on the microcarrier surface.
■ EXPERIMENTAL SECTION
Materials. Poly(dimethylsiloxane) (PDMS) microﬂuidic chips
were produced by using Sylgard 84 (Dow Corning). Four-arm PEG
end-functionalized with thiols (4-arm-PEG-SH, 10 kDa) were
obtained from NOF (Japan) and dissolved in bidistilled water.
Vinylsulfone-functionalized 8-arm-PEG (8-arm-PEG-VS, 10 kDa) was
Received: January 4, 2013
Revised: February 21, 2013
Article
pubs.acs.org/Biomac
© XXXX American Chemical Society A dx.doi.org/10.1021/bm4000162 | Biomacromolecules XXXX, XXX, XXX−XXX
synthesized as described28 and dissolved in triethanolamine (0.3 M,
pH 8). Amine-functionalized magnetic particles (size: 200 nm) were
supplied from Chemicell. Hexadecane and ABIL EM 90 were
purchased from Sigma (U.S.A.) and Evonik Industries (Germany),
respectively. Thiolated gelatin (GelinS) was purchased from Glycosan
Biosystems (U.S.A.), and C-RGD (Ac-GRCGRGDSPG-NH2) was
obtained from GL Biochem (China). Fibronectin fragment FN III9−10
bearing a free N-terminal cysteine was a generous gift from Drs.
Hubbell and Martino.29 Maleimide-activated NeutrAvidin and
recombinant ProteinA were purchased from Pierce (Switzerland)
and Biovision (Switzerland), respectively. Maleimide-PEG-NHS linker
(M.W. 2000 Da) was obtained from JenKem Technology (U.S.A.).
Biotinylation was performed using EZ-link maleimide-PEG2-biotin
from Pierce (Switzerland). Human immunoglobulin (IgG) and bovine
serum albumin (BSA) were purchased from Sigma (U.S.A.).
AlexaFluor594 and AlexaFluor488 carboxylic acid, succinimidyl ester
and AlexaFluor546 C5 maleimide ﬂuorophores were obtained from
Life Technologies (U.S.A.). Tris(2-carboxyethyl)phosphine hydro-
chloride (TCEP) and ethyl iodoacetate were obtained from Thermo
Scientiﬁc (U.S.A.) and Sigma (U.S.A.), respectively.
Fabrication of Microﬂuidic Chips. Clewin software was used to
draw microﬂuidic networks for droplet generation using a T-junction
and a ﬂow focusing design composed of two microchannels for the
water phase, intersected at 90° angle with the main channel for the oil
phase. PDMS chips were fabricated using conventional soft litho-
graphic techniques. The 100 μm deep channels with three diﬀerent
channel widths (100, 200, and 300 μm) were patterned on SU8
masters. Microﬂuidic chips were bonded on oxygen plasma-activated
glass slides (Figure 1A).
Microgel Generation. Computer-controlled syringe pumps
(neMESYS from Cetoni, Germany) were used to control ﬂow rates.
Syringes were ﬁlled with PEG solutions and hexadecane with 2% (w/
Figure 1. Characterization of microﬂuidic droplet formation. (A) Experimental setup used for microgel generation. A PDMS chip was bonded on
top of a glass slide and a chamber was devised to collect microbeads. The enlargement shows the microﬂuidic layout for the 200 μm ﬂow-focusing
design. (B, C) Flow focusing and T-junction designs used to generate microdroplets. Droplet length, L, was measured at diﬀerent ﬂow rate ratios and
for diﬀerent microchannels widths, w. Flow instabilities occurred in the 100 μm ﬂow focusing design and no droplets were generated for ﬂow rate
ratio higher than 0.5. The light and dark blue colors indicate the presence of two diﬀerent phases that do not mix each other under laminar ﬂow
conditions until the water stream is broken oﬀ by the organic phase. (D) Generation of a single droplet via ﬂow focusing (200 μm channel width).
The immiscible ﬂuids form an interface at the junction; a droplet starts growing when the water stream penetrates into the main channel; the
symmetric pressure gradient generated by the oil phase causes the breaking oﬀ of the droplet.41 Frequency of droplet formation 7.5 Hz (here).
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v) ABIL EM surfactant used as oil phase. Tygon tubings were used to
connect the syringes to the microﬂuidic chip inlets. Microgels were
generated by loading two microﬂuidic channels with PEG precursors
with concentrations depending on a speciﬁed molar excess of
functional groups: for a 20% VS-excess, the concentrations of PEG-
VS and PEG-SH were 12% (w/v) and 20% (w/v), respectively. For a
20% SH-excess we chose 8.33% (w/v) and 20% (w/v) precursors,
respectively. The oil phase was removed by ﬁltering microgels with 70
μm cell strainers (BD Biosciences, U.S.A.) and extensive washing with
PBS. Microgels were then swollen in PBS overnight. To render
microgels paramagnetic, magnetic nanoparticles were mixed into the
PEG-SH solution to a ﬁnal concentration of 2.7 mg/mL.
Measurements of Paramagnetism. Microgels with and without
trapped magnetic nanoparticles were lyophilized and ﬁxed with silicon
grease (Dow Corning, Switzerland) into gelatin caps. A MicroMag
3900 Vibrating Sample Magnetometer (Laboratory for Micro- and
Nanotechnology, ETH, Zurich) was used to assess magnetic
properties.
Swelling Measurements. Swelling ratios (Q′) of microgel
formulations were calculated as the ratio between bead volume in
the oil phase after droplet generation (i.e., before swelling) and in the
water phase after swelling to equilibrium. Volumes were calculated
based on the diameters of 200 microbeads per condition measured by
microscopy.
Atomic Force Microscopy Measurements. Glass slides were
treated with 3-mercaptopropyl-trimethoxylsilane (MPS; Sigma-Al-
drich, U.S.A.) in order to expose reactive thiol groups and covalently
attach microgels to the surface of glass slides (Figure S1A).
Measurements were carried out at 12 μm/s speed using a NanoWizard
II atomic force microscope (JPK Instruments, Germany) and conical
silicon nitride probes with a nominal spring constant of 0.65 N/m
(CSC37, Mikromasch, Switzerland), imposing a Z-length of 6 μm.
Force−distance curves were analyzed with JPK Data Processing
software. The Hertz model was applied to calculate the Young’s
modulus, considering a Poisson’s ratio of 0.5 (Figure S1C).
Indentation forces were chosen to have a linear relationship between
the indentation and the applied force. Four diﬀerent forces were
applied, namely, 80, 100, 120, and 140 nN. Young’s moduli were
calculated as averages of elastic moduli at diﬀerent indentation forces.
Each microbead and bulk gel was analyzed at three diﬀerent points and
measurements were carried out on 10 microbeads and 3 bulk gels.
Bioconjugation of Microgels. Protein functionalization of
microgels was carried out by continuous stirring for 2 h at 37 °C
using protein solutions at a concentration of up to 4-fold molar excess
of reactive groups. The pH of the solution was adjusted to 8 by adding
1 M HEPES buﬀer solution at pH 9. Thiolated gelatin and BSA were
ﬂuorescently labeled with AlexaFluor594 or AlexaFluor488. In order to
functionalize SH-bearing microgels, BSA was PEGylated using
maleimide-PEG-NHS. Thiolated gelatin and cysteine-containing
RGD were used to functionalize VS- and SH-bearing microcarriers,
respectively. Mal-NeutrAvidin, Mal-ProteinA, Alexa488-hIgG, biotin-
BSA-DsRed, and biotin-FN III9−10 were prepared as described.
30 After
protein functionalization, microgels were ﬁltered using 70 μm cell
strainers and washed several times with PBS to remove unbound
proteins. Reduction of disulﬁde bonds with TCEP (10 mM) was
performed on both Alexa488-hIgG and DsRed-BSA-biotin function-
alized microcarriers to assess the eﬀect on protein functionalization. A
sulfhydryl blocking agent, ethyl iodoacetate (36 mM), was used to
quench all thiol groups that did not react with maleimide in order to
reduce nonspeciﬁc binding (Figure S3A,B). A second washing step was
performed at the end of the process to remove unbound proteins.
Figure 2. Microﬂuidic synthesis of PEG hydrogel microbeads. (A) Microgels are generated from reactive PEG macromers using a ﬂow focusing
microﬂuidic chip. A chamber collects microgels until completion of cross-linking. (B) Transparent magnetic microgels after removal of the oil phase.
Histogram in lower panel shows the size distribution of magnetic microgels. (C) Hysteresis curves (= applied magnetic ﬁeld (H) vs the
magnetization (M)) demonstrating microgel magnetization. Magnetic particles and microgels with and without magnetic particles were analyzed.
Magniﬁed area shows magnetization of microgels compared to negative control.
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Image Analysis. Images were acquired with an inverted Olympus
IX81 CellR microscope. Fluorescence measurements were performed
using a Matlab script on 15 images per condition, with approximately
10 microgels each. Images were ﬁrst rescaled to a normalized scale
based on homogeneous imaging setup, the objects in the foreground
were identiﬁed and a mask was generated based on bright-ﬁeld images.
A watershed function was used to automatically label beads. Finally,
the average intensity per bead was calculated. Statistical t test (type 2,
number of tails 2) was performed on the samples; ***p < 0.001 and
*p < 0.05.
Adult Stem/Progenitor Cell Culture on Microgels. C2C12
(p7) and placenta-derived human MSCs (isolated and generously
provided by M. Ehrbar and P. Lienemann et al.,31 Department of
Obstetrics, University of Zurich Hospital, Switzerland) were cultured
on tissue culture ﬂasks in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) with 10% Fetal Bovine Serum (FBS) or 10% Fetal Calf
Serum (FCS), pen-strep (10 mg/mL), and sodium pyruvate (1 mM,
Gibco). After dissociation with trypsin (TripLE express, Gibco), cells
were cultured on microcarriers in a suspension bioreactor (BioL-
evitator, Hamilton, Switzerland). During the inoculation phase, the
rotation speed of the tubes was 50 rpm with an agitation period of 2
min for an entire duration of 4 h. The agitation pause duration was set
at 10 min for C2C12 cells and MSCs and 10 min for ESC to minimize
microcarrier “bridging”. During cell culture, the rotation speed was
increased to 80 rpm for all cell types. C2C12 (and ESC, see below)
were seeded on microcarriers at a density of 14200 cells/cm2
(corresponding to ca. 10 cells per carrier), whereas the larger MSCs
were seeded at a density of 2800 cells/cm2 (ca. 2 cells per carrier). A
total of 6 mL of medium was used during the inoculation phase (to
maximize cell-microgel contact) and 20 mL during cell culture.
Medium was replaced every two days by collecting all the microcarriers
on the bottom of the tube by a magnet.
Microgel-based ESC Expansion. R1 Oct4-GFP embryonic stem
cells (ESC) were kindly provided by the Zandstra Laboratory
(University of Toronto, Canada). ESC were cultured on 0.2%
gelatin-coated Petri dishes in DMEM with 15% ESC Screened FBS
(Fisher), pen-strep (10 mg/mL, Invitrogen), sodium pyruvate (1 mM,
Gibco), nonessential amino acids (0.1 mM, Invitrogen), β-
mercaptoethanol (0.1 mM, Life Technologies), and LIF (103 U/mL,
Millipore). ESCs were cultured on PEG microcarriers in bioreactors as
described above. Cells were counted every day by retrieving 1 mL of
sample from the spinner and by passing them through a 70 μm cell
strainer. Microgels were rinsed twice with PBS and trypsinized
(TripLE express, Gibco) for 5 min. The resulting solution containing
cells and microgels was ﬁltered with a strainer and the cells were
counted using a trypan blue exclusion test. Cells were analyzed by ﬂow
cytometry using Cyan ADPS analyzer (Beckman Coulter). Data
analysis was performed with FlowJo software.
■ RESULTS AND DISCUSSION
Characterization of Microﬂuidic Droplet Generation.
To select the most suitable system for the generation of aECM
microgels, we ﬁrst reproduced existing microﬂuidic droplet
formation strategies based on a T-junction32−34 and a ﬂow
focusing design.35−37 Both designs were evaluated at variable
geometries and ﬂow rate ratios, which we deﬁne as the ratio of
ﬂow rates of the aqueous (discontinuous) and oil (continuous)
phase (Figure 1). By keeping the total water ﬂow rate constant
(here: 4 μL/min; 2 μL/min for each inlet based on some of our
earlier microﬂuidic work38), depending on the ﬂow rate ratio,
droplets of spherical or plug-like shape between ca. 90 and 700
μm were formed (Figure S2A). Droplet size decreased with
Figure 3. Generation of microgels with diﬀerent cross-linking densities. (A) Micrographs showing microgels generated with a ﬁnal PEG
concentration of 2.5%, 7.5%, and 15% (w/v) in the oil phase and in water. Images show how microgels swell more at higher PEG concentration.
Microgels were generated with a ﬂow rate ratio of 5 and an oil ﬂow rate of 20 μL/min. (B) Swelling ratio (Q′) of hydrogel microbeads showing a
nearly perfect linear correlation between the PEG concentration and Q′. (C) Microgels formed from softer PEG-co-peptide hydrogels cross-linked
via the transglutaminase factor XIII. The ﬁnal PEG concentration was 2.32% (w/v). Scale bars = 100 μm.
Biomacromolecules Article
dx.doi.org/10.1021/bm4000162 | Biomacromolecules XXXX, XXX, XXX−XXXD
increasing ﬂow rate ratio (Figure 1B,C), as was expected based
on published data.35,36 Moreover, at constant ﬂow rate ratio,
droplet size increased with microchannel width. Notably, at the
same ﬂow rate ratio, droplet dimensions do not change
signiﬁcantly with water ﬂow rate. The stability of the system
was better for high ﬂow rate ratios (Figure S2C). Taken
together, in our hands, microdroplets with variable dimensions
can be readily generated, consistent with earlier work.35,36,39
We next calculated the frequency of droplet formation
deﬁned as the ratio between the ﬂow rate of the discontinuous
phase and the volume of the droplet for a speciﬁc ﬂow rate
ratio.40 We found a frequency range between about 1 Hz for
wide channels at low ﬂow rate ratios and 700 Hz for narrow
channels at high ﬂow rate ratios. However, using smaller
channel dimensions and higher ﬂow rate ratios, smaller droplets
have been generated at frequencies up to tens of kHz.36
Because, in our hands, the ﬂow focusing design allowed for
better control of droplet dimensions and stability across a wide
size range, as well as higher frequencies of droplets of
dimensions in the range of commercially available microcarriers
(100−300 μm Figure 1D and Figure S2B), we chose this design
to generate aECM microgels.
Generation of Microgels with Well-Deﬁned Size and
Physicochemical Properties. PEG-based microgels were
generated by forming droplets composed of mixtures of equal
volumes of two aqueous precursors containing reactive PEG
macromers. Speciﬁcally, the mixing of vinyl sulfone (VS)-
terminated 8-arm-PEG in one channel and thiol (SH)-
terminated 4-arm-PEG in the other channel resulted in
hydrogel formation by stepwise copolymerization via Michael-
Figure 4. Bioconjugation of PEG microgels. (A) Microgels with molar
excess of VS groups (here: 20%) can be functionalized with thiolated
biomolecules (here: ﬂuorescent thiol-activated gelatin). (B) Microgels
with molar excess of SH groups (here: 20%) can be functionalized
with SH-reacting biomolecules (here: ﬂuorescent maleimide-activated
BSA). Scale bars = 100 μm.
Figure 5. Bioconjugation of microgels via aﬃnitiy binding. (A, C) Microgels with a molar excess of SH groups functionalized with maleimide-
ProteinA or maleimide-NeutrAvidin to capture Fc- or biotin-tagged biomolecules, respectively. (B, D) Examples of microgels functionalized with
ProteinA/IgG and NeutrAvidin/biotin-BSA. Measured ﬂuorescence intensities were normalized to the intensity of the negative control (i.e.,
microcarriers not functionalized with ProteinA or NeutrAvidin). Quantiﬁcation shows that ﬂuorescent intensities from modiﬁed microcarriers are
signiﬁcantly higher. Scale bars = 100 μm.
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type addition (Figure 2A).28,30 Importantly, the laminar ﬂow
regime in the microﬂuidic channels avoids premature mixing
and reaction of the two precursors, ensuring a precise control of
the volumes mixed in each individual bead (Movie S1).42−44 As
a result, the size distribution of microgels that was obtained
after removal of the oil phase was very narrow (Figure 2B).35,44
The chosen channel geometry is particularly well suited for
the generation of multicomponent microgels that can, for
example, be obtained by loading diﬀerent gel components into
the precursors streams. For instance, in order to facilitate
medium exchange during bioreactor cell culture, magnetic
particles were loaded into one of the precursor streams to
irreversibly trap them in the microgels. Vibrating sample
magnetometer analysis demonstrates that the resulting micro-
gels are indeed paramagnetic (Figure 2C).
Importantly, by varying the concentration of the PEG
precursors between 2.5 and 15% (w/v), we obtain microgels
with diﬀerent cross-linking densities and thus physicochemical
properties such as swelling ratios (Figure 3A). Using the above
PEG macromere formulations, gel swelling scales are perfectly
linear with PEG concentration (Figure 3B).
Atomic force microscopy was used to measure elastic moduli
of microgels and bulk gels (Figure S1A). At a concentration of
7.5%, we found that elastic moduli of microgels and bulk gels
match well, suggesting that the cross-linking reaction occurs
with similar eﬃciencies at micro- and macro-scale. This may
not be surprising as hydrogelation by stepwise copolymeriza-
Figure 6. Modulation of ligand density on microgel surface. (A) ProteinA-modiﬁed microgels functionalized with diﬀerent amounts of Alexa546
IgG: IgG/PrA = 3:1 (IgG surface density 3.25 nmol/cm2); IgG/PrA = 1:1 (IgG surface density 1.08 nmol/cm2); IgG/PrA = 1/3:1 (IgG surface
density 0.36 nmol/cm2). (B) Image-based ﬂuorescence analysis. Microgel intensity values were normalized to the control (i.e., no functionalization
with IgG). Functionalization with increasing amount of IgG results in signiﬁcantly higher ﬂuorescent intensities. Scale bars = 100 μm.
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tion via Michael-type addition is an eﬃcient process.28
Speciﬁcally, at 20% molar excess of VS groups, we obtain
Young’s moduli of 28.84 ± 4.86 and 31.28 ± 0.42 kPa for 7.5%
microgels and bulk gels, respectively (Figure S1E). At 20%
molar excess of SH groups, we obtained elastic moduli of 28.1
± 5.02 and 32.99 ± 6.21 kPa for microgels and bulk gels,
respectively.
Notably, microgels can also be formed from much softer
PEG-co-peptide hydrogels formulations such as those cross-
linked via Michael-type addition28 (not shown) or the
transglutaminase factor XIII (FXIIIa)45 (Figure 3C). For
instance, at a PEG concentration of 2.3% (w/v), FXIIIa-
cross-linked microbeads with a modulus of about 750 Pa were
obtained. Therefore, droplet microﬂuidics is suitable to
generate PEG-based microgels across a very wide range of
cross-linking densities and mechanical properties (e.g., from
hundreds of Pa up to tens of kPa in Young’s modulus).
Bioconjugation of PEG Microgels via Covalent
Coupling. Next, a bioconjugation protocol was developed to
modify the above, relatively inert microgels with biomolecules
of interest (Figure 4). To this end, microgels were formed at a
slightly imbalanced stoichiometric ratio of functional groups
Figure 7. Stem cell adhesion and growth on PEG microgels in bioreactor culture. (A) C2C12 cultured on RGD-functionalized microgels. (B) MSCs
cultured on FN III9−10-functionalized microgels. Fluorescence micrographs depict phalloidin (cytoskeleton) and DAPI (nuclei) staining for both cell
types on the last day of culture. Magniﬁcations indicate cell spreading on microgels at diﬀerent time points. Scale bars = 100 μm.
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such that free reactive groups on bead surfaces could be used as
“chemical handles” to tether bioactive ligands. PEG precursor
streams of diﬀerent ﬁnal concentrations were thus mixed to
achieve an up to 20% molar excess of one of the reactive
moieties (VS or SH) producing such “activated” gel surfaces.
Networks bearing free VS groups can then be functionalized via
Michael-type addition with thiolated biomolecules (Figure 4A),
whereas SH-presenting networks are amenable for functional-
ization with biomolecules bearing unsaturated groups such as
vinylsulfones, maleimides, acrylates, or acrylamides. Due to its
excellent speciﬁcity toward reaction with thiols, we chose
maleimide groups to demonstrate the latter bioconjugation
strategy (Figure 4B).
An estimation of the maximal protein amount that can be
tethered to the microcarrier surface was carried out, taking into
account the dry mass of the gel and the molar excess of the
reactive VS or SH groups. Assuming a layer (or shell) of 10 nm
on the surface of microcarriers that is accessible for cells to
interact with, we obtain a protein surface density of about 3.45
nmol/cm2 for 7.5% (w/v) microcarriers bearing a 20% molar
excess of VS groups. Similarly, at a 20% molar excess of SH
groups, 7.5% microcarriers yield a maximum of about 3.25
nmol/cm2 of protein.
Bioconjugation of PEG Microgels Using Aﬃnity
Binding Schemes. The versatility of the chosen two-step
bioconjugation strategy allows for functionalization of PEG
microgels using other strategies such as aﬃnity-based protein
capture.30,38 This strategy could be particularly interesting for
modifying microcarriers with recombinant proteins such as
growth factors that are often obtained as “chimeric” proteins
containing a tag for puriﬁcation (e.g., Fc-tag or His-tag). For
example, ProteinA or NeutrAvidin can be tethered to thiol-
bearing microgels using a heterofunctional maleimide-PEG-
NHS linker (Figure 5A,C). These microgels eﬃciently capture
Fc-tagged or biotinylated proteins as shown in Figure 5. Indeed,
ﬂuorescent intensity measurements and image analysis revealed
speciﬁc binding of ﬂuorescent model proteins (IgG and
biotinylated BSA) on ProteinA- or NeutrAvidin-modiﬁed
microgels (Figure 5B,D). Of note, a reduction of disulﬁde
bonds by tris(2-carboxyethyl)phosphine hydrochloride does
not increase the eﬃciency of functionalization (Figure S3).
Next, to demonstrate the possibility to modulate the surface
density of biochemical factors, we functionalized ProteinA-
modiﬁed microgels with diﬀerent molar excess of ﬂuorescent
IgG (Figure 6A). Quantiﬁcation of ﬂuorescent intensities by
image analysis reveals a signiﬁcant increase in concentration
with increasing molar excess of IgG (Figure 6B). Therefore, our
bioconjugation strategy can be applied to control the
concentration of tethered biomolecules.
Peptide or Protein-Functionalized PEG Microgels
Promote Stem/Progenitor Cell Adhesion and Growth.
To validate our aECM microgels in bioreactor-based cell
culture, selective peptide- and protein-modiﬁed formulations
were tested for their ability to promote stem/progenitor cell
adhesion and proliferation (Figure 7). To this end, VS-bearing
microcarriers were functionalized with cysteine-containing
RGD peptide and used to expand C2C12 muscle progenitor
cells (Figure 7A). Moreover, microcarriers presenting an excess
of thiols were functionalized with maleimide-activated Neu-
trAvidin and then with biotinylated ﬁbronectin fragment FN
III9−10 for human mesenchymal stem cell (MSC) culture
(Figure 7B). Micrographs show very good spreading and
adhesion of both cell types on these bioactive PEG microgels.
Compared to C2C12 cultures, a relatively low number of MSCs
was observed on microgels which we attribute to the low initial
cell seeding density (ca. 2800 cells/cm2) and their slower
growth rate, as very few cells were found to detach from the
microgels (Figure 7B).
Gelatin-Functionalized PEG Microgels Promote
Mouse ESC Expansion. As a tractable model system to
probe stem cell expansion on our aECM microgels, we used an
ESC reporter line wherein GFP marks cells that express the
pluripotency transcription factor Oct4. To promote eﬃcient
ESC adhesion, PEG microgels bearing excess VS groups were
modiﬁed with thiolated gelatin, a protein that is routinely used
in ESC expansion culture on plastic dishes.
Figure 8. ESC expansion on PEG microgels in bioreactor cultures. (A) ESC cultured on gelatin-functionalized microgels in the presence or absence
of LIF. Fluorescence micrographs in the left corners indicate Oct4 expression. (B) ESC growth curves depicting cell density (D) for diﬀerent culture
periods. In presence of LIF, cells proliferate more extensively. Partial cell detachment can be observed after 4 days of culture in the absence of LIF.
(C) GFP expression measured by ﬂow cytometry. In the presence of LIF, ESCs maintain high Oct4 expression up to day 4. In the absence of LIF,
Oct4 expression drops dramatically, suggesting ESC diﬀerentiation. Scale bar = 100 μm.
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In the presence of leukemia inhibitory factor (LIF), aECM
microgels promote expansion of Oct4-positive cells under
bioreactor culture conditions (Figure 8A). Cells tended to form
large clusters that often spanned over multiple carriers, a
phenomenon that was previously reported.16,17,46 Upon LIF
removal, cells rapidly lost GFP expression, formed monolayers
instead of larger clusters and ﬁnally detached from the carriers
upon reaching conﬂuency. Moreover, further assessment of
ESC fate by ﬂow cytometry revealed signiﬁcantly less
proliferation (Figure 8B) and lower numbers of GFP-positive
cells (Figure 8C) in the absence of LIF. Of note, these
experiments also show that cells can be readily harvested from
the microgels and used for further analyses such as ﬂow
cytometry or manipulation of cell fate in other culture formats.
■ CONCLUSIONS
Here we demonstrate the application of droplet microﬂuidics
for the reliable generation of monodisperse microgels with
extremely well deﬁned biochemical and biophysical properties.
The versatility of the chosen approach allows us to combine
multiple gel components and additives (such as magnetic
particles) almost at will, providing the exciting opportunity to
generate a huge diversity of microgels for cell manipulation and
screening applications, for example to discover hydrogel
formulations that allow the manipulation of diﬃcult-to-culture
cell types. Our droplet-based aECM fabrication scheme should
also be useful to encapsulate cells in 3D.26,44,47−49
■ ASSOCIATED CONTENT
*S Supporting Information
Additional data are provided. Figure S1 provides further
information about AFM on microgels and bulk gels formed at
diﬀerent VS/SH molar ratios. Figure S2 reports the droplet
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S3 shows ﬂuorescent pictures and measurements carried out on
microcarriers functionalized via aﬃnity binding scheme and
treated with TCEP and ethyl iodoacetate. This material is
available free of charge via the Internet at http://pubs.acs.org.
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